139 related articles for article (PubMed ID: 9704134)
1. [Renal function during water-salt depletion. Effects of alpha-blocking treatment with prazosin].
Agnoli GC; Cacciari M; Garutti C; Lenzi P
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):349-55. PubMed ID: 9704134
[No Abstract] [Full Text] [Related]
2. [Adrenolytic drugs and the restoration of renal vasodilator and water-salt capacity of dopamine under water-salt deprivation conditions].
Agnoli GC; Cacciari M; Garutti C; Lenzi P
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):356-61. PubMed ID: 9704135
[No Abstract] [Full Text] [Related]
3. [Dependence of various methods of control of renal function on the water-salt content of the organism and on the level of activity of the adrenergic system].
Agnoli GC; Cacciari M; Cocco G; Garutti C; Lenzi P
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):362-8. PubMed ID: 9704136
[No Abstract] [Full Text] [Related]
4. Adrenergic blocking agents and the kidney.
Bauer JH
J Clin Hypertens; 1985 Sep; 1(3):199-221. PubMed ID: 2872278
[TBL] [Abstract][Full Text] [Related]
5. [Extrinsic catecholaminergic control of the renal function during water and salt depletion].
Agnoli GC; Cacciari M; Cocco G; Garutti C; Lenzi P
Arch Sci Med (Torino); 1983; 140(1):9-27. PubMed ID: 6307216
[TBL] [Abstract][Full Text] [Related]
6. [Further studies on the reactivity of renal catecholamine receptors in man in water-salt depletion].
Agnoli GC; Borgatti R; Cacciari M; Dorigoni S; Garutti C; Ikonomu E; Lenzi P
Cardiologia; 1985 May; 30(5):387-94. PubMed ID: 3833351
[No Abstract] [Full Text] [Related]
7. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
8. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
Moreira TS; Takakura AC; Menani JV; Colombari E
Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
[TBL] [Abstract][Full Text] [Related]
9. Effects of prazosin therapy on BP, renal function, and body fluid composition.
Bauer JH; Jones LB; Gaddy P
Arch Intern Med; 1984 Jun; 144(6):1196-200. PubMed ID: 6732379
[TBL] [Abstract][Full Text] [Related]
10. [Low-dose dopamine as an activator of renal catecholamine receptors of different classes. II. Studies in water-saline depletion and associated adrenergic blockade].
Agnoli GC; Borgatti R; Cacciari M; Dorigoni S; Garutti C; Ikonomu E; Lenzi P
Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1949-54. PubMed ID: 6097293
[TBL] [Abstract][Full Text] [Related]
11. alpha-Adrenoceptor subtypes mediating regional kidney blood flow responses to renal nerve stimulation.
Eppel GA; Lee LL; Evans RG
Auton Neurosci; 2004 May; 112(1-2):15-24. PubMed ID: 15233926
[TBL] [Abstract][Full Text] [Related]
12. FK 506-induced nephrotoxicity in rats.
Kumano K; Wang G; Endo T; Kuwao S
Transplant Proc; 1991 Feb; 23(1 Pt 1):512-5. PubMed ID: 1703696
[No Abstract] [Full Text] [Related]
13. [Suppression, by beta-adrenergic receptor blockade, of the sympathomimetic component of dopamine renal action in water-saline depletion].
Agnoli GC; Cacciari M; Garutti C; Lenzi P
Boll Soc Ital Biol Sper; 1980 May; 56(9):946-52. PubMed ID: 6108775
[TBL] [Abstract][Full Text] [Related]
14. Adrenoreceptors and renal function.
Wallin JD
J Clin Hypertens; 1985 Jun; 1(2):171-8. PubMed ID: 2873207
[TBL] [Abstract][Full Text] [Related]
15. Renal water and sodium handling during gradated unilateral ureter obstruction.
Pedersen TS; Hvistendahl JJ; Djurhuus JC; Frøkiaer J
Scand J Urol Nephrol; 2002; 36(3):163-72. PubMed ID: 12201929
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of intravenous cyclosporine on renal function in healthy humans.
Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
Transplant Proc; 1989 Feb; 21(1 Pt 1):915-7. PubMed ID: 2705255
[No Abstract] [Full Text] [Related]
18. Intrarenal effects of phenoxybenzamine on sodium reabsorption.
Strandhoy JW; Schneider EG; Willis LR; Knox FG
J Lab Clin Med; 1974 Feb; 83(2):263-70. PubMed ID: 4149359
[No Abstract] [Full Text] [Related]
19. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
[TBL] [Abstract][Full Text] [Related]
20. 6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-phenoxycyclopentyl)amino] methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel alpha 1-adrenergic receptor antagonist and renal vasodilator.
McCarthy JR; Zimmerman MB; Trepanier DL; LeTourneau ME; Wiedeman PE; Whitten JP; Broersma RJ; Shea PJ; Wiech NL; Huffman JC
J Med Chem; 1985 Sep; 28(9):1142-5. PubMed ID: 2863377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
